Wei Y - Search Results

1

Screening of FDA-approved drugs identifies sutent as a modulator of UCP1 expression in brown adipose tissue.

Qiu Y, Sun Y, Xu D, Yang Y, Liu X, Wei Y, Chen Y, Feng Z, Li S, Reyad-Ul Ferdous M, Zhao Y, Xu H, Lao Y, Ding Q. Qiu Y, et al. Among authors: wei y. EBioMedicine. 2018 Nov;37:344-355. doi: 10.1016/j.ebiom.2018.10.019. Epub 2018 Oct 20. EBioMedicine. 2018. PMID: 30348622 Free PMC article.

2

Use of genome editing tools in human stem cell-based disease modeling and precision medicine.

Wei YD, Li S, Liu GG, Zhang YX, Ding QR. Wei YD, et al. Yi Chuan. 2015 Oct;37(10):983-91. doi: 10.16288/j.yczz.15-239. Yi Chuan. 2015. PMID: 26496750 Review.

3

[Efficient genome editing in human pluripotent stem cells through CRISPR/Cas9].

Liu GG, Li S, Wei YD, Zhang YX, Ding QR. Liu GG, et al. Yi Chuan. 2015 Nov;37(11):1167-73. doi: 10.16288/j.yczz.15-240. Yi Chuan. 2015. PMID: 26582531 Chinese.

4

CRISPR/Cas9 with single guide RNA expression driven by small tRNA promoters showed reduced editing efficiency compared to a U6 promoter.

Wei Y, Qiu Y, Chen Y, Liu G, Zhang Y, Xu L, Ding Q. Wei Y, et al. RNA. 2017 Jan;23(1):1-5. doi: 10.1261/rna.057596.116. Epub 2016 Oct 14. RNA. 2017. PMID: 27742910 Free PMC article.

5

Prevention of Muscle Wasting by CRISPR/Cas9-mediated Disruption of Myostatin In Vivo.

Wei Y, Chen Y, Qiu Y, Zhao H, Liu G, Zhang Y, Meng Q, Wu G, Chen Y, Cai X, Wang H, Ying H, Zhou B, Liu M, Li D, Ding Q. Wei Y, et al. Mol Ther. 2016 Nov;24(11):1889-1891. doi: 10.1038/mt.2016.192. Mol Ther. 2016. PMID: 27916995 Free PMC article. No abstract available.

6

Genetic and Chemical Screenings Identify HDAC3 as a Key Regulator in Hepatic Differentiation of Human Pluripotent Stem Cells.

Li S, Li M, Liu X, Yang Y, Wei Y, Chen Y, Qiu Y, Zhou T, Feng Z, Ma D, Fang J, Ying H, Wang H, Musunuru K, Shao Z, Zhao Y, Ding Q. Li S, et al. Among authors: wei y. Stem Cell Reports. 2018 Jul 10;11(1):22-31. doi: 10.1016/j.stemcr.2018.05.001. Epub 2018 May 31. Stem Cell Reports. 2018. PMID: 29861165 Free PMC article.

7

Gain-of-Function Mutations of SLC16A11 Contribute to the Pathogenesis of Type 2 Diabetes.

Zhao Y, Feng Z, Zhang Y, Sun Y, Chen Y, Liu X, Li S, Zhou T, Chen L, Wei Y, Ma D, Lui KO, Ying H, Chen Y, Ding Q. Zhao Y, et al. Among authors: wei y. Cell Rep. 2019 Jan 22;26(4):884-892.e4. doi: 10.1016/j.celrep.2018.12.100. Cell Rep. 2019. PMID: 30673611 Free article.

8

Identification of a rhodanine derivative BML-260 as a potent stimulator of UCP1 expression.

Feng Z, Wei Y, Zhang Y, Qiu Y, Liu X, Su L, Liang N, Yin H, Ding Q. Feng Z, et al. Among authors: wei y. Theranostics. 2019 May 26;9(12):3501-3514. doi: 10.7150/thno.31951. eCollection 2019. Theranostics. 2019. PMID: 31281493 Free PMC article.

9

In Vivo AAV-CRISPR/Cas9-Mediated Gene Editing Ameliorates Atherosclerosis in Familial Hypercholesterolemia.

Zhao H, Li Y, He L, Pu W, Yu W, Li Y, Wu YT, Xu C, Wei Y, Ding Q, Song BL, Huang H, Zhou B. Zhao H, et al. Among authors: wei y. Circulation. 2020 Jan 7;141(1):67-79. doi: 10.1161/CIRCULATIONAHA.119.042476. Epub 2019 Nov 29. Circulation. 2020. PMID: 31779484

10

Genome-scale CRISPR screening for potential targets of ginsenoside compound K.

Yang Y, Liu X, Li S, Chen Y, Zhao Y, Wei Y, Qiu Y, Liu Y, Zhou Z, Han J, Wu G, Ding Q. Yang Y, et al. Among authors: wei y. Cell Death Dis. 2020 Jan 20;11(1):39. doi: 10.1038/s41419-020-2234-5. Cell Death Dis. 2020. PMID: 31959745 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

24,752 results

Search Page

Filters